Compare EOG Resources Inc (EOG) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs Repligen Corporation Common Stock — how do they compare? EOG Resources Inc trades at $155 (market cap $80.34B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: EOG Resources Inc is far larger — about 7.2× Repligen Corporation Common Stock's market cap, and EOG Resources Inc pays a 2.66% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and Repligen Corporation Common Stock for 0 Days on average.
| EOG | RGEN | |
|---|---|---|
Market Cap | $80.34B | $11.14B |
Volume | 2,309,813 | 1,259,263 |
Sector | Energy | Health |
52-Week High | $154.19 | $194.57 |
52-Week Low | $101.78 | $102.87 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $83.69B | $11.02B |
Dividend Yield | 2.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $153.17, up 1.77% with strong technical momentum and bullish moving averages. The company maintains robust profitability with 25.81% net margins and consistent earnings beats, though revenue declined to $22.58B in 2025. Analyst consensus remains strongly positive with 59% buy ratings and a $163.50 price target, while recent CFO transition and dividend payments highlight stable corporate governance.
EOG presents a compelling value opportunity with attractive valuation multiples (P/E 11.92, EV/EBITDA 6.02) and strong cash generation. Key risks include oil price volatility and capital expenditure intensity, but disciplined capital allocation and projected 2026 revenue growth to $26.6B support upside potential toward analyst targets.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
